Does ADO-TRASTUZUMAB EMTANSINE Cause Disease progression? 750 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 750 reports of Disease progression have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 8.6% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.
750
Reports of Disease progression with ADO-TRASTUZUMAB EMTANSINE
8.6%
of all ADO-TRASTUZUMAB EMTANSINE reports
223
Deaths
181
Hospitalizations
How Dangerous Is Disease progression From ADO-TRASTUZUMAB EMTANSINE?
Of the 750 reports, 223 (29.7%) resulted in death, 181 (24.1%) required hospitalization, and 25 (3.3%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 750 reports have been filed with the FAERS database.
What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?
Nausea (780)
Fatigue (774)
Diarrhoea (654)
Off label use (630)
Thrombocytopenia (519)
Death (509)
Neuropathy peripheral (506)
Headache (465)
Platelet count decreased (453)
Metastases to central nervous system (386)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Disease progression Risk?
ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA